Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

FDA requests additional information for Dermagraft PMA

Feb. 27, 2001

Novel antipruritic agents in development at Pfizer

Feb. 23, 2001

Access reports positive phase III data for OraDisc canker sore treatment

Feb. 21, 2001

Botulinum toxin type A preparation proves safe and effective in axillary hyperhidrosis

Feb. 21, 2001

Cellegy accelerates filing for Anogesic in Canada

Feb. 21, 2001

Protopic for severe atopic dermatitis launched in U.S.

Feb. 20, 2001

Phase II trial establishes safety and optimal dose of PVAC psoriasis treatment

Feb. 19, 2001

Switch Biotech acquires delivery system for skin wounds

Feb. 15, 2001

In vitro study provides support for development of CS-891 as Rx for alopecia

Feb. 9, 2001

Phenyl ureas for the treatment of chemokine-mediated diseases

Feb. 8, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...